Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV
- PMID: 38224711
- DOI: 10.1016/S0140-6736(24)00048-5
Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV
Conflict of interest statement
We declare no competing interests.
Comment on
-
Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.Lancet. 2024 Jan 27;403(10424):365-378. doi: 10.1016/S0140-6736(23)02631-4. Epub 2024 Jan 12. Lancet. 2024. PMID: 38224710 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
